EUVIMEDEUVIMED entdecken
Multizentrische StudieFall-Kontroll-Studie

Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study

Eleonora Colombo, Alberto Doretti, Renata Rao, Federico Verde, Martina Sodano, Anna De Gobbi, Francesca Schiano di Cola, Giulia Ceccardi, Beatrice Fiducia, Virginia Quaresima, Chiara Tolassi, Andrea Rizzardi und 10 weitere

Neurological Sciences · 2025

DOI: 10.1007/s10072-025-08011-2 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Neurological Sciences, 2025. Verfasst von Eleonora Colombo und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Via Mosè Bianchi 90, 20149, Milan, Italy. Hauptthemen laut MEDLINE: Neurofilament Proteins, Migraine Disorders, Glial Fibrillary Acidic Protein. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Plasma glial fibrillary acidic protein (pGFAP) and plasma neurofilament light chain (pNfL) levels reflect astrocyte activation and neuronal damage, respectively. Whether these phenomena play a role in migraine is unknown. This study aimed to compare pGFAP and pNfL levels in patients with chronic migraine (CM) and age-matched controls and to analyze their relation with clinical features. METHODS: The study evaluated two independent cohorts of patients, including in total 58 CM and 69 controls. pGFAP and pNfL were quantified with single molecule array (Simoa) technology. Demographic and clinical data were collected for each subject; differences in NfL/GFAP levels between CM and controls were evaluated in analyses adjusted for the effect of age and sex; clinical characteristics associated with NfL/GFAP levels were separately evaluated in the two cohorts. RESULTS: In both cohorts, we did not find a significant difference in pGFAP or pNFL levels between CM and matched controls. The study did not find any correlation between pGFAP or pNfL levels and any migraine characteristics (namely presence of migraine aura, attack frequency, migraine intensity, years of disease). CONCLUSIONS: Our negative results support the assumption that migraine represents a benign condition, characterized by transient functional brain alterations and not by the accumulation over time of neuroaxonal damage and/or associated astrocyte activation detectable by neurodegeneration marker proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofilament ProteinsMigraine DisordersGlial Fibrillary Acidic ProteinHumansFemaleMaleAdultCase-Control StudiesMiddle AgedChronic DiseaseBiomarkers

Stichwörter der Autor:innen

Astrocyte activationChronic migraineGlial fibrillary acidic proteinNeurofilament light chainNeurological damagePlasma biomarkers

Substanzen

Neurofilament ProteinsGlial Fibrillary Acidic Proteinneurofilament protein LGFAP protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Via Mosè Bianchi 90, 20149, Milan, Italy.
  • Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Via Mosè Bianchi 90, 20149, Milan, Italy. alberto.doretti@gmail.com.
  • Department of Continuity of Care and Frailty, Neurology Unit, ASST Spedali Civili Hospital, Brescia, Italy.
  • Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università Degli Studi di Milano, Via Francesco Sforza 35, 20122, Milan, Italy.
  • Department of Medical Biotechnology and Translational Medicine, Università Degli Studi di Milano, Via Vanvitelli 32, 20129, Milan, Italy.
  • Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Förderung

  • Ministero della Salute

Zitieren

APA

Colombo, E., Doretti, A., Rao, R., Verde, F., Sodano, M., De Gobbi, A., di Cola, F. S., Ceccardi, G., Fiducia, B., Quaresima, V., Tolassi, C., Rizzardi, A., Pierro, S., Thirumoorthi, V., Bettinelli, A., Ungaro, D., Ratti, A., Silani, V., Messina, S., …, & Ticozzi, N. (2025). Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study. Neurological Sciences. https://doi.org/10.1007/s10072-025-08011-2

Vancouver

Colombo E, Doretti A, Rao R, Verde F, Sodano M, De Gobbi A, et al. Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study. Neurological Sciences. 2025. doi:10.1007/s10072-025-08011-2

BibTeX
@article{Colombo2025,
  author = {Colombo, Eleonora and Doretti, Alberto and Rao, Renata and Verde, Federico and Sodano, Martina and De Gobbi, Anna and di Cola, Francesca Schiano and Ceccardi, Giulia and Fiducia, Beatrice and Quaresima, Virginia and Tolassi, Chiara and Rizzardi, Andrea and Pierro, Simone and Thirumoorthi, Vineetha and Bettinelli, Arianna and Ungaro, Daniela and Ratti, Antonia and Silani, Vincenzo and Messina, Stefano and Pilotto, Andrea and Padovani, Alessandro and Ticozzi, Nicola},
  title = {Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-025-08011-2}
}
Kostenlos starten →